Herlapsa 250mg Tablet

Herlapsa 250mg Tablet contains Lapatinib as its active ingredient. It is used in the treatment of HER2-positive breast cancer, either alone or in combination with other anti-cancer medicines. The drug works by blocking the activity of the human epidermal growth factor receptor-2 (HER2), slowing down or stopping the growth of cancer cells. Doctors determine the Herlapsa 250mg dosage for breast cancer based on the patient's condition, response to treatment, and any other medicines being used. It is usually taken once daily on an empty stomach or as advised by a medical professional. Regular monitoring of liver function, heart activity, and blood counts is recommended during treatment. The Herlapsa 250mg composition includes Lapatinib Ditosylate Monohydrate, which helps target cancer cells that produce excess HER2 protein. This targeted action makes it particularly effective in managing advanced and metastatic breast cancer. Patients with HER2-positive breast cancer often evaluate Herlapsa 250mg in comparison to Tykerb, as both contain the same active ingredient (Lapatinib) and work in a similar manner. However, pricing and manufacturer may differ, leading some patients to prefer one over the other. Many Herlapsa 250mg reviews highlight its effectiveness in controlling disease progression when used as prescribed and monitored carefully. For affordability and accessibility, patients can check the Herlapsa 250mg price in India through verified pharmacies. The cost may vary depending on region, pharmacy discounts, and whether it is purchased offline or online. Patients can also procure Herlapsa 250mg online from authorised medical platforms that require a valid prescription. This ensures product authenticity and safe delivery. Based on medical advice or in case of non-availability, your oncologist may recommend a Herlapsa 250mg substitute in India with a similar composition and therapeutic action. Substitution should always be undertaken under the supervision of a healthcare provider, as treatment response and tolerability may vary. The Herlapsa 250mg manufacturer follows strict quality standards and ensures the medicine meets all safety and efficacy benchmarks before distribution. It is widely prescribed by oncologists across India for HER2-positive breast cancer.

herlapsa 250mg uses are Treats advanced or HER2 Positive metastatic breast cancer.

Lapatinib in Herlapsa 250mg Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and Epidermal growth factor receptors (EGFRs) from signalling, which are produced by breast cancer cells. It kills cancer cells and slows down their growth.

Take Herlapsa 250mg Tablet exactly as prescribed by your doctor. Take this medicine at least 1 hour before or after taking the food. Swallow the tablet and do not crush, open, or dissolve them.

Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them. Herlapsa 250mg tablet side effects Serious Diarrhea Severe allergic reactions Skin rash Heart problems Common Loss of appetite Nausea, vomiting Tiredness, weakness Indigestion Constipation Sore mouth or mouth ulcers Stomach pain Trouble sleeping Back pain Pain in the hands and feet Joint or back pain Cough, breathlessness Headache Nose bleed Hot flush Unusual hair loss Dry skin and itching

Herlapsa 250mg Tablet can cause severe diarrhea; drink plenty of water during treatment. Follow a well-balanced diet to support your health while on medication. Avoid grapefruit juice during treatment, as it can interfere with how the medicine works. This medicine makes the skin more sensitive to sunlight, increasing the risk of rashes. Limit sun exposure and always apply a sunscreen with good SPF before going outside. Wash your skin with a soap-free cleanser to reduce irritation.